MML Investors Services
CRL icon

MML Investors Services’s Charles River Laboratories CRL Stock Holding History

MML Investors Services’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.46M Buy
10,860
+3,747
+53% +$667K 0.01% 1404
2026
Q1 		$1.23M Sell
7,113
-1,895
-21% -$351K ﹤0.01% 1636
2025
Q4 		$1.8M Buy
9,008
+520
+6% +$94.3K ﹤0.01% 1433
2025
Q3 		$1.33M Sell
8,488
-453
-5% -$71.9K ﹤0.01% 1540
2025
Q2 		$1.36M Sell
8,941
-3,989
-31% -$532K ﹤0.01% 1485
2025
Q1 		$1.95M Buy
12,930
+280
+2% +$46.9K 0.01% 1191
2024
Q4 		$2.33M Sell
12,650
-801
-6% -$154K 0.01% 1052
2024
Q3 		$2.65M Sell
13,451
-613
-4% -$127K 0.01% 951
2024
Q2 		$2.9M Sell
14,064
-707
-5% -$160K 0.01% 871
2024
Q1 		$4M Buy
14,771
+2,256
+18% +$539K 0.02% 740
2023
Q4 		$2.96M Buy
12,515
+1,400
+13% +$275K 0.01% 828
2023
Q3 		$2.18M Sell
11,115
-53
-0.5% -$10.9K 0.01% 869
2023
Q2 		$2.35M Buy
11,168
+5,781
+107% +$1.15M 0.01% 837
2023
Q1 		$1.09M Sell
5,387
-212
-4% -$48K 0.01% 1028
2022
Q4 		$1.22M Buy
5,599
+121
+2% +$26.4K 0.01% 1040
2022
Q3 		$1.08M Sell
5,478
-745
-12% -$161K 0.01% 1022
2022
Q2 		$1.33M Buy
6,223
+464
+8% +$113K 0.01% 916
2022
Q1 		$1.64M Buy
5,759
+1,059
+23% +$327K 0.01% 879
2021
Q4 		$1.77M Buy
4,700
+454
+11% +$176K 0.01% 810
2021
Q3 		$1.75M Buy
4,246
+389
+10% +$162K 0.01% 778
2021
Q2 		$1.43M Buy
3,857
+214
+6% +$71.5K 0.01% 857
2021
Q1 		$1.06M Buy
3,643
+1,168
+47% +$325K 0.01% 900
2020
Q4 		$618K Sell
2,475
-381
-13% -$90.7K 0.01% 1050
2020
Q3 		$647K Sell
2,856
-385
-12% -$79.9K 0.01% 932
2020
Q2 		$565K Buy
3,241
+371
+13% +$59.2K 0.01% 943
2020
Q1 		$362K Sell
2,870
-349
-11% -$52.3K 0.01% 1007
2019
Q4 		$492K Buy
3,219
+20
+0.6% +$2.77K 0.01% 1010
2019
Q3 		$423K Sell
3,199
-637
-17% -$85.4K 0.01% 1013
2019
Q2 		$544K Sell
3,836
-188
-5% -$25.5K 0.01% 982
2019
Q1 		$584K Buy
4,024
+341
+9% +$44.8K 0.01% 935
2018
Q4 		$417K Sell
3,683
-886
-19% -$111K 0.01% 994
2018
Q3 		$615K Buy
4,569
+361
+9% +$44.6K 0.01% 897
2018
Q2 		$472K Buy
4,208
+661
+19% +$71.5K 0.01% 868
2018
Q1 		$379K Buy
3,547
+568
+19% +$61.2K 0.01% 964
2017
Q4 		$326K Buy
2,979
+887
+42% +$96.5K 0.01% 1050
2017
Q3 		$226K Buy
+2,092
New +$215K ﹤0.01% 1151

Other funds holding CRL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

MML Investors Services's CRL Position: Q2 2026 in Review

MML Investors Services increased its Charles River Laboratories (CRL) stake by 53% in Q2 2026, buying an estimated $667K and bringing the position to 10,860 shares worth $2.46M. The position accounts for 0.01% of the portfolio, ranked #1404.

MML Investors Services first reported a position in CRL in Q3 2017 and has held it in 36 quarters since. The position peaked at $4M in Q1 2024. 287 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • MML Investors Services held 10,860 shares of Charles River Laboratories worth $2.46M as of Q2 2026.
  • MML Investors Services bought 3,747 Charles River Laboratories shares in Q2 2026, an estimated $667K.
  • Charles River Laboratories made up 0.01% of MML Investors Services's portfolio in Q2 2026, its #1404 holding.
  • MML Investors Services first reported a position in Charles River Laboratories in Q3 2017 and has held it in 36 quarters since.
  • MML Investors Services's Charles River Laboratories position peaked at $4M in Q1 2024.
  • 287 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.